← Back to Clinical Trials
Recruiting NCT06670495
HPV Genotype Attribution and Disease Burden of Anal Cancer in China
Trial Parameters
Condition Anal Cancer
Sponsor Fudan University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 300
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2025-06-01
Completion 2027-12-31
Brief Summary
To demonstrate HPV prevalence and its genotype distributions in anal cancer in China and to describe demographic and clinical features of HPV-related anal cancer in China; To describe the epidemiological characteristics ,trends and of disease burden of anal cancer in China
Eligibility Criteria
Inclusion Criteria: * (1) Patients diagnosed with anal cancers, (2) Patients without radiation or chemotherapy prior to specimen collection; Exclusion Criteria: * (1) Patients with HIV infection, (2) Patients with immunosuppression after solid organ transplantation, (3) Those who do not agree to specimen collection and testing, (4) For retrospective study cases, those who without specimen.
Related Trials
NCT06366841
Stigma and Psychological profilE in REctal-anal caNcer pAtients
View Trial →
NCT06327568
Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal
View Trial →
NCT06670495
HPV Genotype Attribution and Disease Burden of Anal Cancer in China
View Trial →